Steadily Growing Molecular Data (MKD) Heads Towards $2 Mark: Time To Buy?

In January 2020 Molecular Data (NASDAQ: MKD) stock had a good price tag but the pandemic-related stock market crash ruined it obviously.

Later in June 2020 MKD suddenly grew after falling to as deep as $1.40. Then in July, it had a spike at $2.90 on the volume of millions of shares. It happened due to slow emerging markets’ activities that naturally pushed the demand for chemicals to soar in a short period of time.

Being a very vital participant in a global supply chain makes Molecular Data have a solid growing revenue but earnings are still negative perhaps due to repaying huge loans after it was hit by the pandemic. Let’s see MKD’s strength in reaching $2 again. Hopefully, it won’t get bought by whales who often try to artificially push the price above a reasonable point.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.

Want Hot Stocks?    Yes. I Love Them No thanks